Most active investors · All time

Ranked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.

Browse by month

241

Concord Health PartnersLatest Sep 2

Thyme Care · >$125M Series E Scan.com · $220M Series C equity + debt facilities

2rounds

0led

Healthtech 2

Series C+ 2

Sep 2, 2026

Details

New companies 2 · Follow-on 0

Stages: Series C+ 2

Thyme Care >$125M Series E Scan.com $220M Series C equity + debt facilities

242

HealthQuest CapitalLatest Sep 2

Thyme Care · >$125M Series E Connie Health · $40M Series B

2rounds

0led

Healthtech 2

Series B 1, Series C+ 1

Sep 2, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Series C+ 1

Thyme Care >$125M Series E Connie Health $40M Series B

243

Polaris PartnersLatest Aug 30

Faro AI · $37.3M Series B Tavo Biotherapeutics · $17M Series A

2rounds

0led

Biotech 1Healthtech 1

Series A 1, Series B 1

Aug 30, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series B 1

Faro AI $37.3M Series B Tavo Biotherapeutics $17M Series A

244

S32Latest Aug 30

Faro AI · $37.3M Series B Network Bio · $50M Strategic

2rounds

1led

Biotech 1Healthtech 1

Series B 1, Undisclosed 1

Aug 30, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Undisclosed 1

Faro AI $37.3M Series B Network Bio $50M Strategic

245

Ten13Latest Aug 26

Arintra · $25M Series B Vexev · $6M Undisclosed

2rounds

—led

Healthtech 2

Series B 1, Undisclosed 1

Aug 26, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Undisclosed 1

Arintra $25M Series B Vexev $6M Undisclosed

246

Village GlobalLatest Aug 26

Legato · $12M Seed Blossom Health · $20M Seed+Series A

2rounds

—led

Healthtech 2

Seed 1, Undisclosed 1

Aug 26, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Undisclosed 1

Legato $12M Seed Blossom Health $20M Seed+Series A

247

Fifth Down CapitalLatest Aug 25

Hike Medical · $22.5M Seed+Series A Chapter · $100M Series E

2rounds

—led

Healthtech 2

Series C+ 1, Undisclosed 1

Aug 25, 2026

Details

New companies 2 · Follow-on 0

Stages: Series C+ 1, Undisclosed 1

Hike Medical $22.5M Seed+Series A Chapter $100M Series E

248

Angel InvestLatest Aug 19

Aisel Health · €1.7M Pre-Seed dehaze · €3.2M Seed

2rounds

—led

Healthtech 2

Pre-seed 1, Seed 1

Aug 19, 2026

Details

New companies 2 · Follow-on 0

Stages: Pre-seed 1, Seed 1

Aisel Health €1.7M Pre-Seed dehaze €3.2M Seed

249

Brandenburg KapitalLatest Aug 19

AssistMe · €6.5M Undisclosed Cellbricks Therapeutics · €10M Seed+Non-Dilutive

2rounds

0led

Biotech 1Healthtech 1

Undisclosed 2

Aug 19, 2026

Details

New companies 2 · Follow-on 0

Stages: Undisclosed 2

AssistMe €6.5M Undisclosed Cellbricks Therapeutics €10M Seed+Non-Dilutive

250

CRB Health TechLatest Aug 19

AssistMe · €6.5M Undisclosed Circle Health · €9M Seed

2rounds

1led

Healthtech 2

Seed 1, Undisclosed 1

Aug 19, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Undisclosed 1

AssistMe €6.5M Undisclosed Circle Health €9M Seed

251

LifeXLatest Aug 19

Aisel Health · €1.7M Pre-Seed Ilant Health · $15M Series A

2rounds

—led

Healthtech 2

Pre-seed 1, Series A 1

Aug 19, 2026

Details

New companies 2 · Follow-on 0

Stages: Pre-seed 1, Series A 1

Aisel Health €1.7M Pre-Seed Ilant Health $15M Series A

252

TMVLatest Aug 19

Ours Privacy · $15M Series A Novellia · $18M Series A

2rounds

—led

Healthtech 2

Series A 2

Aug 19, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 2

Ours Privacy $15M Series A Novellia $18M Series A

253

Newpath PartnersLatest Aug 17

Leal Therapeutics · $30M Series A CREATE Medicines · $122M Series B

2rounds

—led

Biotech 2

Series A 1, Series B 1

Aug 17, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series B 1

Leal Therapeutics $30M Series A CREATE Medicines $122M Series B

254

Lilly Asia VenturesLatest Aug 13

Khartis Therapeutics · $50M Series B Pulnovo Medical · $100M Strategic

2rounds

—led

Biotech 1Healthtech 1

Series B 1, Undisclosed 1

Aug 13, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Undisclosed 1

Khartis Therapeutics $50M Series B Pulnovo Medical $100M Strategic

255

Longwood FundLatest Aug 13

Khartis Therapeutics · $50M Series B Mediar Therapeutics · $76M Series B

2rounds

—led

Biotech 2

Series B 2

Aug 13, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 2

Khartis Therapeutics $50M Series B Mediar Therapeutics $76M Series B

256

M VenturesLatest Aug 12

Remepy · $36M Series A Vizgen · $48M Series A

2rounds

—led

Biotech 2

Series A 2

Aug 12, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 2

Remepy $36M Series A Vizgen $48M Series A

257

O.G. Venture PartnersLatest Aug 12

Remepy · $36M Series A Neko Health · $700M Series C

2rounds

—led

Biotech 1Healthtech 1

Series A 1, Series C+ 1

Aug 12, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series C+ 1

Remepy $36M Series A Neko Health $700M Series C

258

Soleus CapitalLatest Aug 12

Bridge to Life · $110M Series C+Debt Crystalys Therapeutics · $130M Series B

2rounds

—led

Biotech 1Healthtech 1

Series B 1, Undisclosed 1

Aug 12, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Undisclosed 1

Bridge to Life $110M Series C+Debt Crystalys Therapeutics $130M Series B

259

OffscriptLatest Aug 10

Flagler Health · $50M Series B Throne Science · $10M Series A

2rounds

—led

Healthtech 2

Series A 1, Series B 1

Aug 10, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series B 1

Flagler Health $50M Series B Throne Science $10M Series A

260

NewHealth VenturesLatest Aug 4

QuantHealth · $45M Series B 9amHealth · $26M Series B

2rounds

—led

Biotech 1Healthtech 1

Series B 2

Aug 4, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 2

QuantHealth $45M Series B 9amHealth $26M Series B

261

Pitango HealthTechLatest Aug 4

QuantHealth · $45M Series B Connie Health · $40M Series B

2rounds

—led

Biotech 1Healthtech 1

Series B 2

Aug 4, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 2

QuantHealth $45M Series B Connie Health $40M Series B

262

Dunamu & PartnersLatest Aug 3

Inocras · $31M Series B Nitra · $187M Series A+Series B+Debt

2rounds

—led

Biotech 1Healthtech 1

Series B 1, Undisclosed 1

Aug 3, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 1, Undisclosed 1

Inocras $31M Series B Nitra $187M Series A+Series B+Debt

263

InterVestLatest Aug 3

Inocras · $31M Series B Vitestro · $70M Series B

2rounds

—led

Biotech 1Healthtech 1

Series B 2

Aug 3, 2026

Details

New companies 2 · Follow-on 0

Stages: Series B 2

Inocras $31M Series B Vitestro $70M Series B

264

Shangbay CapitalLatest Jul 30

SoundHealth · $12.3M Series A Nervonik · $52.5M Series B

2rounds

—led

Healthtech 2

Series A 1, Series B 1

Jul 30, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series B 1

SoundHealth $12.3M Series A Nervonik $52.5M Series B

265

Granite Financial HoldingsLatest Jul 29

Precise Behavioral · $14.2M Growth Greater Good Health · $20.5M Series B

2rounds

—led

Healthtech 2

Growth 1, Series B 1

Jul 29, 2026

Details

New companies 2 · Follow-on 0

Stages: Growth 1, Series B 1

Precise Behavioral $14.2M Growth Greater Good Health $20.5M Series B

266

MeltwindLatest Jul 29

Qureight · $20M Series B IMU Biosciences · $53M Series A

2rounds

—led

Biotech 1Healthtech 1

Series A 1, Series B 1

Jul 29, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series B 1

Qureight $20M Series B IMU Biosciences $53M Series A

267

Molten VenturesLatest Jul 29

Qureight · $20M Series B IMU Biosciences · $53M Series A

2rounds

—led

Biotech 1Healthtech 1

Series A 1, Series B 1

Jul 29, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series B 1

Qureight $20M Series B IMU Biosciences $53M Series A

268

Catalyst Health VenturesLatest Jul 28

Epitel, Inc. · $26M Series B Rejoni · $25M Series A

2rounds

—led

Healthtech 2

Series A 1, Series B 1

Jul 28, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series B 1

Epitel, Inc. $26M Series B Rejoni $25M Series A

269

Elikon VentureLatest Jul 28

CORE Biomedicine · $21M Series A Fortitude Biomedicines · $13M Seed

2rounds

—led

Biotech 2

Seed 1, Series A 1

Jul 28, 2026

Details

New companies 2 · Follow-on 0

Stages: Seed 1, Series A 1

CORE Biomedicine $21M Series A Fortitude Biomedicines $13M Seed

270

Mitsubishi UFJ Capital CoLatest Jul 28

CORE Biomedicine · $21M Series A Rege Nephro Co · $10.6M Series C

2rounds

—led

Biotech 2

Series A 1, Series C+ 1

Jul 28, 2026

Details

New companies 2 · Follow-on 0

Stages: Series A 1, Series C+ 1

CORE Biomedicine $21M Series A Rege Nephro Co $10.6M Series C

“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.